|
|||||
|
|
Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma |
|
| Institution: | 1. Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington;2. Seattle Cancer Care Alliance, Seattle, Washington;3. Department of Clinical Pharmacy, University of California, San Francisco, California;4. Department of Medicine, Division of Hematology/Oncology/Blood and Marrow Transplant, University of California, San Francisco, California;5. Department of Laboratory Medicine, University of California, San Francisco, California |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |